Interpretable, Probability-Based Confidence Metric for Continuous Quantitative Structure-Activity Relationship Models

被引:32
|
作者
Keefer, Christopher E. [1 ]
Kauffman, Gregory W. [3 ]
Gupta, Rishi Raj [2 ]
机构
[1] Pfizer Inc, Computat ADME Grp, Dept Pharmacokinet Dynam & Drug Metab, Groton, CT 06340 USA
[2] Pfizer Inc, Res Ctr Emphasis, Groton, CT 06340 USA
[3] Pfizer Inc, Neurosci Res Unit, Worldwide Med Chem, Cambridge, MA 02139 USA
关键词
QSAR; APPLICABILITY; DOMAIN; SIMILARITY; SET;
D O I
10.1021/ci300554t
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A great deal of research has gone into the development of robust confidence in prediction and applicability domain (AD) measures for quantitative structure-activity relationship (QSAR) models in recent years. Much of the attention has historically focused on structural similarity, which can be defined in many forms and flavors. A concept that is frequently overlooked in the realm of the QSAR applicability domain is how the local activity landscape plays a role in how accurate a prediction is or is not. In this work, we describe an approach that pairs information about both the chemical similarity and activity landscape of a test compound's neighborhood into a single calculated confidence value. We also present an approach for converting this value into an interpretable confidence metric that has a simple and informative meaning across data sets. The approach will be introduced to the reader in the context of models built upon four diverse literature data sets. The steps we will outline include the definition of similarity used to determine nearest neighbors (NN), how we incorporate the NN activity landscape with a similarity-weighted root-mean-square distance (wRMSD) value, and how that value is then calibrated to generate an intuitive confidence metric for prospective application. Finally, we will illustrate the prospective performance of the approach on five proprietary models whose predictions and confidence metrics have been tracked for more than a year.
引用
收藏
页码:368 / 383
页数:16
相关论文
共 50 条
  • [1] Quantitative structure-activity relationship models for compounds with anticonvulsant activity
    Bellera, Carolina L.
    Talevi, Alan
    EXPERT OPINION ON DRUG DISCOVERY, 2019, 14 (07) : 653 - 665
  • [2] Quantitative structure-activity relationship models for bee toxicity
    Toropov, Andrey A.
    Toropova, Alla P.
    Como, Francesca
    Benfenati, Emilio
    TOXICOLOGICAL AND ENVIRONMENTAL CHEMISTRY, 2017, 99 (7-8) : 1117 - 1128
  • [3] Advances in quantitative structure-activity relationship models of antimalarials
    Roy, Kunal
    Ojha, Probir Kumar
    EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (08) : 751 - 778
  • [4] Advances in quantitative structure-activity relationship models of antioxidants
    Roy, Kunal
    Mitra, Indrani
    EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (11) : 1157 - 1175
  • [5] Quantitative Structure-Activity Relationship Models That Stand the Test of Time
    Davis, Andrew M.
    Wood, David J.
    MOLECULAR PHARMACEUTICS, 2013, 10 (04) : 1183 - 1190
  • [6] A PRACTICAL OVERVIEW OF QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP
    Nantasenamat, Chanin
    Isarankura-Na-Ayudhya, Chartchalerm
    Naenna, Thanakorn
    Prachayasittikul, Virapong
    EXCLI JOURNAL, 2009, 8 : 74 - 88
  • [7] Complementary Quantitative Structure-Activity Relationship Models for the Antitrypanosomal Activity of Sesquiterpene Lactones
    Kimani, Njogu M.
    Matasyoh, Josphat C.
    Kaiser, Marcel
    Nogueira, Mauro S.
    Trossini, Gustavo H. G.
    Schmidt, Thomas J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (12)
  • [8] Development of Predictive Quantitative Structure-Activity Relationship Models of Epipodophyllotoxin Derivatives
    Naik, Pradeep Kumar
    Dubey, Abhishek
    Kumar, Rishay
    JOURNAL OF BIOMOLECULAR SCREENING, 2010, 15 (10) : 1194 - 1203
  • [9] Recent advances in quantitative structure-activity relationship models of antimalarial drugs
    Ojha, Probir Kumar
    Kumar, Vinay
    Roy, Joyita
    Roy, Kunal
    EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (06) : 659 - 695
  • [10] On some aspects of validation of predictive quantitative structure-activity relationship models
    Roy, Kunal
    EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (12) : 1567 - 1577